Haleon (NYSE: HLN) Posts Lower-Than-Expected Q3 Revenue as Panadol Sales Lag in Key Markets
On Thursday, Haleon (NYSE: HLN) missed third-quarter revenue and profit expectations, partly hurt by a stronger pound and lower sales […]
NYSE: HLN
Pfizer (NYSE: PFE) Cuts Haleon Stake to 15%, Selling $3.3 Billion in Shares
Pfizer (NYSE: PFE) sold a stake in British consumer healthcare group Haleon (NYSE: HLN) worth about $3.26 billion on Monday,
Pfizer (NYSE: PFE) Cuts Haleon Stake to 15%, Selling $3.3 Billion in Shares Read More »
Haleon (NYSE: HLN) to Raise Stake in China JV
Haleon (NYSE: HLN) plans to increase its stake in its Chinese joint venture to 88% from 55%, the British consumer
Haleon (NYSE: HLN) to Raise Stake in China JV Read More »
